Fluorine in PDB 9cj1: Dual Phosphorylated Human P38 Alpha Bound to Nilotinib
Enzymatic activity of Dual Phosphorylated Human P38 Alpha Bound to Nilotinib
All present enzymatic activity of Dual Phosphorylated Human P38 Alpha Bound to Nilotinib:
2.7.11.24;
Protein crystallography data
The structure of Dual Phosphorylated Human P38 Alpha Bound to Nilotinib, PDB code: 9cj1
was solved by
E.J.Stadnicki,
H.Ludewig,
R.Prem Kumar,
D.Kern,
N.Bradshaw,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.74 /
1.80
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
38.137,
67.195,
63.016,
90,
97.8,
90
|
R / Rfree (%)
|
18.6 /
23.2
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Dual Phosphorylated Human P38 Alpha Bound to Nilotinib
(pdb code 9cj1). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
Dual Phosphorylated Human P38 Alpha Bound to Nilotinib, PDB code: 9cj1:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 9cj1
Go back to
Fluorine Binding Sites List in 9cj1
Fluorine binding site 1 out
of 3 in the Dual Phosphorylated Human P38 Alpha Bound to Nilotinib
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Dual Phosphorylated Human P38 Alpha Bound to Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F402
b:52.9
occ:1.00
|
F4
|
A:NIL402
|
0.0
|
52.9
|
1.0
|
C2
|
A:NIL402
|
1.4
|
47.7
|
1.0
|
F3
|
A:NIL402
|
2.2
|
50.3
|
1.0
|
F1
|
A:NIL402
|
2.2
|
41.3
|
1.0
|
C5
|
A:NIL402
|
2.4
|
36.6
|
1.0
|
C12
|
A:NIL402
|
2.9
|
30.0
|
1.0
|
C6
|
A:NIL402
|
3.4
|
39.6
|
1.0
|
CG1
|
A:VAL83
|
3.9
|
34.0
|
1.0
|
C11
|
A:NIL402
|
4.2
|
34.6
|
1.0
|
CD1
|
A:ILE141
|
4.3
|
38.1
|
1.0
|
SD
|
A:MET78
|
4.5
|
42.9
|
1.0
|
O
|
A:ILE166
|
4.6
|
34.3
|
1.0
|
C8
|
A:NIL402
|
4.6
|
43.9
|
1.0
|
CG2
|
A:ILE84
|
4.6
|
40.2
|
1.0
|
CD2
|
A:LEU75
|
4.8
|
34.5
|
1.0
|
CG1
|
A:ILE141
|
4.8
|
30.3
|
1.0
|
C9
|
A:NIL402
|
4.9
|
36.0
|
1.0
|
CG
|
A:MET78
|
4.9
|
41.3
|
1.0
|
O17
|
A:NIL402
|
5.0
|
33.1
|
1.0
|
CD2
|
A:LEU74
|
5.0
|
51.5
|
1.0
|
CA
|
A:LEU167
|
5.0
|
33.1
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 9cj1
Go back to
Fluorine Binding Sites List in 9cj1
Fluorine binding site 2 out
of 3 in the Dual Phosphorylated Human P38 Alpha Bound to Nilotinib
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Dual Phosphorylated Human P38 Alpha Bound to Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F402
b:50.3
occ:1.00
|
F3
|
A:NIL402
|
0.0
|
50.3
|
1.0
|
C2
|
A:NIL402
|
1.4
|
47.7
|
1.0
|
F1
|
A:NIL402
|
2.2
|
41.3
|
1.0
|
F4
|
A:NIL402
|
2.2
|
52.9
|
1.0
|
C5
|
A:NIL402
|
2.4
|
36.6
|
1.0
|
C6
|
A:NIL402
|
2.8
|
39.6
|
1.0
|
C12
|
A:NIL402
|
3.7
|
30.0
|
1.0
|
CD2
|
A:HIS148
|
3.8
|
28.9
|
1.0
|
O
|
A:HOH510
|
4.1
|
51.8
|
1.0
|
CD1
|
A:ILE141
|
4.1
|
38.1
|
1.0
|
C8
|
A:NIL402
|
4.2
|
43.9
|
1.0
|
O
|
A:HOH587
|
4.3
|
51.9
|
1.0
|
NE2
|
A:HIS148
|
4.4
|
27.3
|
1.0
|
CG
|
A:HIS148
|
4.5
|
24.1
|
1.0
|
CD2
|
A:LEU74
|
4.5
|
51.5
|
1.0
|
CG2
|
A:ILE146
|
4.7
|
39.0
|
1.0
|
CG1
|
A:ILE141
|
4.7
|
30.3
|
1.0
|
CG2
|
A:ILE141
|
4.7
|
34.8
|
1.0
|
C11
|
A:NIL402
|
4.8
|
34.6
|
1.0
|
CB
|
A:HIS148
|
4.8
|
25.6
|
1.0
|
CA
|
A:HIS148
|
4.9
|
25.8
|
1.0
|
CB
|
A:ASP168
|
4.9
|
31.1
|
1.0
|
C9
|
A:NIL402
|
5.0
|
36.0
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 9cj1
Go back to
Fluorine Binding Sites List in 9cj1
Fluorine binding site 3 out
of 3 in the Dual Phosphorylated Human P38 Alpha Bound to Nilotinib
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Dual Phosphorylated Human P38 Alpha Bound to Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F402
b:41.3
occ:1.00
|
F1
|
A:NIL402
|
0.0
|
41.3
|
1.0
|
C2
|
A:NIL402
|
1.4
|
47.7
|
1.0
|
F3
|
A:NIL402
|
2.2
|
50.3
|
1.0
|
F4
|
A:NIL402
|
2.2
|
52.9
|
1.0
|
C5
|
A:NIL402
|
2.4
|
36.6
|
1.0
|
C12
|
A:NIL402
|
2.9
|
30.0
|
1.0
|
C
|
A:LEU167
|
3.3
|
30.9
|
1.0
|
CD2
|
A:HIS148
|
3.4
|
28.9
|
1.0
|
NE2
|
A:HIS148
|
3.5
|
27.3
|
1.0
|
C6
|
A:NIL402
|
3.5
|
39.6
|
1.0
|
O
|
A:LEU167
|
3.6
|
31.6
|
1.0
|
N
|
A:ASP168
|
3.6
|
32.6
|
1.0
|
CA
|
A:LEU167
|
3.6
|
33.1
|
1.0
|
CB
|
A:ASP168
|
3.8
|
31.1
|
1.0
|
CG2
|
A:ILE166
|
3.9
|
27.8
|
1.0
|
N
|
A:LEU167
|
4.1
|
29.8
|
1.0
|
O
|
A:ILE166
|
4.2
|
34.3
|
1.0
|
C11
|
A:NIL402
|
4.2
|
34.6
|
1.0
|
C
|
A:ILE166
|
4.3
|
31.8
|
1.0
|
CA
|
A:ASP168
|
4.3
|
37.4
|
1.0
|
O17
|
A:NIL402
|
4.5
|
33.1
|
1.0
|
CG
|
A:HIS148
|
4.5
|
24.1
|
1.0
|
CE1
|
A:HIS148
|
4.6
|
31.4
|
1.0
|
C8
|
A:NIL402
|
4.6
|
43.9
|
1.0
|
CD1
|
A:ILE141
|
4.7
|
38.1
|
1.0
|
CB
|
A:ILE166
|
4.9
|
30.4
|
1.0
|
C9
|
A:NIL402
|
4.9
|
36.0
|
1.0
|
O
|
A:HOH510
|
4.9
|
51.8
|
1.0
|
CG
|
A:ASP168
|
5.0
|
43.3
|
1.0
|
|
Reference:
E.J.Stadnicki,
H.Ludewig,
R.P.Kumar,
X.Wang,
Y.Qiao,
D.Kern,
N.Bradshaw.
Dual-Action Kinase Inhibitors Influence P38 Alpha Map Kinase Dephosphorylation. Biorxiv 2024.
ISSN: ISSN 2692-8205
PubMed: 39149408
DOI: 10.1101/2024.05.15.594272
Page generated: Wed Nov 27 17:32:33 2024
|